{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:32:16Z","timestamp":1785879136582,"version":"3.56.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.nrleng.2021.09.012","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T16:13:22Z","timestamp":1682525602000},"page":"523-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Botulinum toxin type A infiltration in spasticity and cervical dystonia. Muscle morphology: an overlooked factor"],"prefix":"10.1016","volume":"39","author":[{"given":"M.","family":"Murie-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bahamonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Graffigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hontanilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2021.09.012_bib0005","first-page":"241","article-title":"Pharmacological denervation of skeletal muscle in chick embryos treated with botulinum toxin","volume":"90","author":"Drachman","year":"1965","journal-title":"Trans Am Neurol Assoc"},{"key":"10.1016\/j.nrleng.2021.09.012_bib0010","doi-asserted-by":"crossref","first-page":"394","DOI":"10.5334\/tohm.321","article-title":"History of botulinum toxin treatment in movement disorders","volume":"6","author":"Jabbari","year":"2016","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"10.1016\/j.nrleng.2021.09.012_bib0015","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.pmrj.2017.02.014","article-title":"OnabotulinumtoxinA for lower limb spasticity: guidance from a delphi panel approach","volume":"9","author":"Esquenazi","year":"2017","journal-title":"PM R"},{"issue":"3","key":"10.1016\/j.nrleng.2021.09.012_bib0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00702-021-02312-4","article-title":"Consensus guidelines for botulinum toxin therapy: General algorithms and dosing tables for dystonia and spasticity","volume":"128","author":"Dressler","year":"2021","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.nrleng.2021.09.012_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8329306","article-title":"Efficacy and safety of botulinum toxin type A for limb spasticity after stroke: A meta-analysis of randomized controlled trials","volume":"2019","author":"Sun","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.nrleng.2021.09.012_bib0030","article-title":"Botulinum toxin type A therapy for cervical dystonia","volume":"12","author":"Castel\u00e3o","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.nrleng.2021.09.012_bib0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/mus.25721","article-title":"Effects of repeated abobotulinumtoxinA injections in upper limb spasticity","volume":"57","author":"Gracies","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nrleng.2021.09.012_bib0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/toxins10010018","article-title":"Ultrasound guidance for botulinum neurotoxin chemodenervation procedures","volume":"10","author":"Alter","year":"2017","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.nrleng.2021.09.012_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2015.01.033","article-title":"Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke","volume":"350","author":"Santamato","year":"2015","journal-title":"J Neurol Sci"},{"issue":"Suppl 1","key":"10.1016\/j.nrleng.2021.09.012_bib0050","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.parkreldis.2011.06.016","article-title":"Accurate targeting of botulinum toxin injections: how to and why","volume":"17","author":"Lim","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.nrleng.2021.09.012_bib0055","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/gerona\/60.2.148","article-title":"Differences in size, strength, and power of upper and lower body muscle groups in young and older men","volume":"60","author":"Candow","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.nrleng.2021.09.012_bib0060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000069495","article-title":"A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke","volume":"15","author":"Pittock","year":"2003","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrleng.2021.09.012_bib0065","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1212\/WNL.0000000000003789","article-title":"TOWER study investigators. Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study","volume":"88","author":"Wissel","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2021.09.012_bib0070","article-title":"High-dose botulinum toxin therapy: safety, benefit, and endurance of efficacy","volume":"10","author":"Chiu","year":"2020","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"10.1016\/j.nrleng.2021.09.012_bib0075","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.toxicon.2018.01.018","article-title":"Towards flexible and tailored botulinum neurotoxin dosing regimens for focal dystonia and spasticity - Insights from recent studies","volume":"147","author":"Wissel","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.nrleng.2021.09.012_bib0080","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s40261-018-0701-x","article-title":"Safety profile of high-dose botulinum toxin type A in post-stroke spasticity treatment","volume":"38","author":"Baricich","year":"2018","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.nrleng.2021.09.012_bib0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47968-x","article-title":"In vivo muscle morphology comparison in post-stroke survivors using ultrasonography and diffusion tensor imaging","volume":"9","author":"K\u00f6rting","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.nrleng.2021.09.012_bib0090","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/mus.20284","article-title":"Pathophysiology of spastic paresis. I: Paresis and soft tissue changes","volume":"31","author":"Gracies","year":"2005","journal-title":"Muscle Nerve"}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580823000287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580823000287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T10:16:28Z","timestamp":1725272188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173580823000287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2173580823000287"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2021.09.012","relation":{},"ISSN":["2173-5808"],"issn-type":[{"value":"2173-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum toxin type A infiltration in spasticity and cervical dystonia. Muscle morphology: an overlooked factor","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2021.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2021.09.016","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}